APA (7th ed.) Citation

Curtis, J., Grabner, M., Burge, R., Teng, C., Shan, M., Garrelts, A., . . . Isenberg, K. (2021). PBI12 Healthcare Resource Utilization and Costs in Patients with Psoriasis Who Switched to Biologic or Phosphodiesterase 4 Inhibitor Therapies Due to Inadequate Response. Value in health, 24, S16. https://doi.org/10.1016/j.jval.2021.04.083

Chicago Style (17th ed.) Citation

Curtis, J.R, M. Grabner, R. Burge, C.C Teng, M. Shan, A. Garrelts, T. Ridenour, and K. Isenberg. "PBI12 Healthcare Resource Utilization and Costs in Patients with Psoriasis Who Switched to Biologic or Phosphodiesterase 4 Inhibitor Therapies Due to Inadequate Response." Value in Health 24 (2021): S16. https://doi.org/10.1016/j.jval.2021.04.083.

MLA (9th ed.) Citation

Curtis, J.R, et al. "PBI12 Healthcare Resource Utilization and Costs in Patients with Psoriasis Who Switched to Biologic or Phosphodiesterase 4 Inhibitor Therapies Due to Inadequate Response." Value in Health, vol. 24, 2021, p. S16, https://doi.org/10.1016/j.jval.2021.04.083.